Recent results from a study being conducted by US company, Grail, reveal that its ‘liquid biopsy’ analysis of blood samples is showing promise in diagnosing a number of cancers – including pancreatic – in their early stages.
The Leeds RAG Fashion Show – the annual flagship event in the calendar of Leeds University Union’s charity fundraising society – takes place on 28 February 2019, with PCRF as one of its nominated charities.
Pancreatic Cancer Research Fund is the only national charity exclusively funding pancreatic cancer research across the UK. We rely on public donations for all of our income, so your contribution is vital. See our secure payment options below.
Many families nowadays are deciding to ask for donations to charity as an alternative to flowers for a funeral.
Treatment of pancreatic cancer might be enhanced by zapping tumours with electricity alongside drug treatments, according to a PCRF-funded project at University College Cork.
Five new cutting edge projects worth just over £1 million have been funded by PCRF. The five projects started in 2023 and the majority run for three years.
Pancreatic cancer often spreads to the liver and can take hold more easily because the immune system does not detect and kill the cancer cells. Professor Schmid has identified a protein that is found at unusually high levels in liver tumours of pancreatic cancer patients. In animal tests, blocking this protein slowed the pace of the tumour’s growth in the liver, so Prof Schmid aims to identify the best way to suppress this protein in pancreatic cancer patients to improve survival
Pancreatic Cancer Research Fund is the national charity dedicated exclusively to supporting research to improve diagnosis and treatment of pancreatic cancer.
Professor Dive is analysing pancreatic cancer cells circulating in the blood. The aim is to develop a profiling technique using blood samples.
PCRF-funded scientists have found a way to target and knock out a single protein that they have discovered is widely involved in pancreatic cancer cell growth, survival and invasion.